Education
About Us
Working with TipRanks
Follow Us
Nurexone Biologic Inc. (TSE:NRX)
:NRX
NRX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.46 - C$0.87
Previous CloseN/A
VolumeN/A
Average Volume (3M)44.51K
Market Cap
C$37.95M
Enterprise ValueC$33.74M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)0.00
Price to Earnings (P/E)―
Beta-0.92
Next Earnings
May 21, 2025EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding55,814,674
10 Day Avg. Volume26,161
30 Day Avg. Volume44,512
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-9.60
P/FCF Ratio619.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$2.61Price Target Upside289.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
---
NurExone Biologic News
PremiumCompany Announcements
NurExone’s ExoPTEN Shows Promising Preclinical Results for Spinal Cord Injury
PremiumCompany Announcements
NurExone Biologic to Showcase Ophthalmology Innovations at MIXiii 2025
PremiumCompany Announcements
NurExone Biologic Earns Spot on 2025 TSX Venture 50™PremiumCompany Announcements
NurExone Biologic Raises Over C$1.2 Million and Appoints New R&D DirectorPremiumCompany Announcements
NurExone Biologic Advances Exosome Therapy with Key Acquisition---
Options Prices
Currently, No data available
---
Ownership Overview
8.46% Insiders
―
Mutual Funds
― Other Institutional Investors
91.54% Public Companies and
Individual Investors
NRX FAQ
What was Nurexone Biologic Inc.’s price range in the past 12 months?
Nurexone Biologic Inc. lowest stock price was C$0.46 and its highest was C$0.87 in the past 12 months.
What is Nurexone Biologic Inc.’s market cap?
Nurexone Biologic Inc.’s market cap is C$37.95M.
When is Nurexone Biologic Inc.’s upcoming earnings report date?
Nurexone Biologic Inc.’s upcoming earnings report date is May 21, 2025 which is in 48 days.
How were Nurexone Biologic Inc.’s earnings last quarter?
Nurexone Biologic Inc. released its earnings results on Mar 27, 2025. The company reported -C$0.029 earnings per share for the quarter, the consensus estimate of -C$0.029 by C$0.
Is Nurexone Biologic Inc. overvalued?
According to Wall Street analysts Nurexone Biologic Inc.’s price is currently Undervalued.
Does Nurexone Biologic Inc. pay dividends?
Nurexone Biologic Inc. does not currently pay dividends.
What is Nurexone Biologic Inc.’s EPS estimate?
Nurexone Biologic Inc.’s EPS estimate is -0.03.
How many shares outstanding does Nurexone Biologic Inc. have?
Nurexone Biologic Inc. has 55,814,674 shares outstanding.
What happened to Nurexone Biologic Inc.’s price movement after its last earnings report?
Nurexone Biologic Inc. reported an EPS of -C$0.029 in its last earnings report, expectations of -C$0.029. Following the earnings report the stock price went down -1.449%.
Which hedge fund is a major shareholder of Nurexone Biologic Inc.?
Currently, no hedge funds are holding shares in TSE:NRX
---
NurExone Biologic Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$2.61 (289.55% Upside)
C$2.61 (289.55% Upside)
Insider Transactions
Sold Shares
Worth C$15.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.66%
12-Months-Change
Fundamentals
Return on Equity
-233.86%
Trailing 12-Months
Asset Growth
155.93%
Trailing 12-Months
Company Description
Nurexone Biologic Inc.
EnerSpar Corp is a Canada based company. Its business is the acquisition, exploration, and development of resource property especially in the field of industrial minerals. Its project includes the Johan Beetz Feldspar property.
---
NRX Stock 12 Month Forecast
Average Price Target
C$2.61
▲(289.55% Upside)
Technical Analysis
Best Analysts Covering NRX
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-11.60%
initiated a buy rating 4 months ago
Copying Siddharth Rajeev's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -11.60% per trade.
---